Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GenLives is a Uruguay-based healthcare biotechnology company focused on clinical genomics and precision medicine services. The company provides whole-genome, whole-exome, and targeted gene-panel testing combined with bioinformatic, genetic, and clinical interpretation to help diagnose rare and inherited diseases, assess genetic risk, support pharmacogenomics, and inform reproductive decisions. GenLives also operates GenLives Pro, a physician-facing collaborative platform that supports ordering tests, managing patients, and reviewing results. Its offering appears to be service-driven rather than a therapeutic drug pipeline, with an emphasis on making genomic medicine more accessible to clinicians and patients in Uruguay and the broader region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GenLives.